The award is given in recognition of an outstanding clinical paper in the field of hip and knee arthroplasty, according to a Dec. 22 press release sent to Becker’s.
Dr. Ford’s study investigated the use of extended postoperative oral tranexamic acid for total knee arthroplasty.
His research found that the drug controls bleeding in patients and has anti-inflammatory effects. The study found that patients who received tranexamic acid via a pill after surgery had significant knee flexion, improved motion, and better pain and functional scores than the patients who did not use postoperative oral tranexamic acid.
Dr. Ford has advanced fellowship training in hip and knee replacement, resurfacing and preservation for Campbell. He also performs a large volume of primary total hip and knee replacements in the mid-South each year, according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
